Departments of 1 Medicine and
3 Clinical Physiology,
2 Turku Positron Emission Tomography Centre, There are no
studies comparing myocardial metabolism between endurance- and
resistance-trained athletes. We used
2-deoxy-2-[18F]fluoro-D-glucose and positron
emission tomography combined with the euglycemic hyperinsulinemic clamp
technique to compare the ability of insulin to stimulate myocardial,
skeletal muscle, and whole body glucose uptake between weight lifters
(n = 8), endurance athletes (n = 8), and sedentary
men (n = 9). Maximal aerobic power (ml · kg
positron emission tomography; imaging; exercise; training
BOTH AEROBIC TRAINING AND RESISTANCE TRAINING
induce structural changes in the heart, such as an increase in left
ventricular mass. With aerobic training, this has been suggested to
occur via an increase in venous return (preload), which causes
eccentric hypertrophy, and an increase in left ventricular diameter
relative to left ventricular wall thickness (1, 14, 17). In contrast, resistance training has been suggested to induce, perhaps via repeated
increases in systolic blood pressure (afterload), concentric hypertrophy, which is characterized by thickening of septal and left
ventricular walls relative to the left ventricular diastolic diameter
(6, 7, 9, 14). These findings, combined with occasional reports of
large blood pressure responses to heavy resistance activity, have even
raised some concerns about whether resistance training is
safe for individuals with hypertension or other cardiovascular diseases
(14).
We have previously demonstrated that patients with essential
hypertension and endurance-trained athletes exhibit opposite alterations in myocardial glucose uptake under hyperinsulinemic conditions, when glucose is the predominant fuel for the myocardium. In
patients with essential hypertension, myocardial glucose uptake, per
unit mass of myocardium, is increased in proportion to cardiac work
(23), whereas myocardial glucose uptake per unit mass of myocardium is
decreased in endurance athletes (18). In the latter group, the lower
glucose uptake per unit mass was interpreted to reflect increased use
of an alternative fuel or lower oxygen consumption per unit mass of the
enlarged left ventricle (18). It is unknown whether resistance training
alters heart glucose metabolism similarly in endurance- and
resistance-trained athletes. In skeletal muscle, aerobically trained
athletes have enhanced insulin sensitivity of glucose uptake, whereas
insulin sensitivity in weight lifters is similar to that in sedentary
subjects (36). The latter conclusion was based on calculation of muscle
glucose uptake with whole body glucose uptake and body composition data (36), rather than on direct measurement. In the present study we
compared insulin-stimulated rates of glucose uptake, measured directly
in the heart and in skeletal muscle in aerobically trained and
resistance-trained subjects using positron emission tomography (PET)
and 2-deoxy-2-[18F]fluoro-D-glucose
([18F]FDG). Heart size and dimensions were determined
with echocardiography. Our results reveal a clear difference in
skeletal muscle insulin sensitivity but a similarly reduced rate of
glucose uptake per unit mass of myocardium in both groups of athletes
compared with sedentary men.
Subjects.
Eight male endurance athletes (runners, cross-country skiers,
triathlonists), eight weight lifters (power lifters), and nine sedentary healthy men participated in the study (Table
1). All athletes were competing at the
national level and trained 4-6 times per week. The control group
did not exercise regularly. The subjects were healthy as judged by
history, physical examination, and routine laboratory tests and were
not taking any medications. The nature, purpose, and potential risks of
the study were explained to all subjects before written informed
consent was obtained. The experimental protocol was reviewed and
approved by the Commission of Ethics of Turku University and Turku
University Central Hospital.
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
1 · min
1)
was higher in the endurance athletes (71 ± 2,
P < 0.001) than the weight lifters (42 ± 2) and the
sedentary men (42 ± 2). Skeletal muscle glucose uptake
(µmol · kg
muscle
1 · min
1) was
enhanced in the endurance athletes (125 ± 16, P < 0.01) but was similar in weight lifters (59 ± 12) and sedentary
(63 ± 7) men. The rate of glucose uptake per unit mass of
myocardium (µmol · kg
1 · min
1)
was similarly decreased in endurance athletes (544 ± 50) and weight
lifters (651 ± 45) compared with sedentary men (1,041 ± 78,
P < 0.001 vs. endurance athletes and weight lifters). Both groups of athletes had increased left ventricular mass. Consequently, total left ventricular glucose uptake was comparable in all groups. These data demonstrate that aerobic but not resistance training is
associated with enhanced insulin sensitivity in skeletal muscle. Despite this, cardiac changes are remarkably similar in weight lifters
and endurance athletes and are characterized by an increase in left
ventricular mass and diminished insulin-stimulated glucose uptake per
heart mass.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
Table 1.
Characteristics of the subjects
Study design. All subjects were studied after a 10- to 12-h overnight fast. The subjects had not exercised for 2 days before the study. Two catheters were inserted, one in an antecubital vein for infusion of glucose and insulin and injection of [18F]FDG and another retrogradely in a heated hand for sampling of arterialized venous blood. Whole body, skeletal, and heart muscle glucose uptake rates were thereafter determined by combining the euglycemic hyperinsulinemic clamp technique with [18F]FDG and PET, as we will describe in detail.
Whole body glucose uptake.
Whole body glucose uptake was quantitated by use of the euglycemic
hyperinsulinemic clamp technique (2). Serum insulin was increased for
120 min by a primed-continuous (1 mU · kg 1 · min
1)
infusion of insulin (Velosulin, Novo Nordisk, Bagsvaerd, Denmark). Normoglycemia was maintained using a variable rate infusion of 20%
glucose based on plasma glucose measurements, which were performed every 5 min from arterialized venous blood. Whole body glucose uptake
was calculated from the glucose infusion rate during the period of PET
scanning (60-120 min). Serum free insulin, plasma lactate, and
serum free fatty acid concentrations were measured every 30 min during hyperinsulinemia.
Heart and skeletal muscle glucose uptake. [18F]FDG was synthesized with an automatic apparatus (10). The [18F]FDG study was performed as previously described (18). [18F]FDG (6-7 mCi or 220-260 MBq) was injected intravenously over 2 min. A dynamic scan of the thoracic region was performed for 40 min and continued with a dynamic scan of the femoral region for 25 min. Plasma radioactivity was measured with an automatic gamma counter (Wizard 1480 3", Wallac, Turku, Finland). An eight-ring ECAT 931/08-tomograph (Siemens/CTI, Knoxville, TN) with an axial resolution of 6.7 mm and in-plane resolution of 6.5 mm was used. Before the emission scan, a transmission scan was performed. All data were corrected for deadtime, decay, and measured photon attenuation. Dynamic FDG scans were reconstructed into a 128 × 128 matrix using a Hann filter with a cut-off frequency of 0.5. Final in-plane resolution of the reconstructed images was 8 mm.
For determination of myocardial glucose uptake, three (lateral, anterior, septal) regions of interest (ROIs) were drawn on at least four representative midventricular slices, with care taken to avoid myocardial borders. All myocardial time-activity curves were corrected for partial volume effect and spillover from cavity (28). ROIs within femoral muscles were drawn as previously described (22). The three-compartment model of [18F]FDG kinetics (29) and graphical analysis according to Patlak and Blasberg (24) were used to quantitate the rates of glucose uptake as previously described (22).Echocardiography.
M-mode and two-dimensional echocardiography (model SSD-870, Aloka,
Tokyo, Japan) was performed according to the
recommendations of the American Society of Echocardiography (26). Left
ventricular (LV) mass was calculated according to the Penn convention
(3): LV mass = 1.04 · [(end diastolic
diameter + posterior wall thickness + septal
thickness)3 end diastolic diameter3]
13.6 g.
Maximal aerobic power and body composition.
Maximal aerobic power
(O2max) was determined
using direct measurement of the rate of oxygen consumption and a cycle
ergometer (model 800 S, Ergoline, Mijnhardt, The Netherlands) with a
continuous incremental protocol. Body fat content was estimated from
four skinfolds (subscapular, triceps brachii, biceps brachii, and
crista iliaca) as measured with a caliper (4).
Other measurements. Blood pressure and heart rate were determined every 30 min throughout the study using an automatic oscillometric blood pressure analyzer (model HEM-705C, Omron, Tokyo, Japan). Plasma glucose was measured using the glucose oxidase method (GM7 Analyser, Analox Instruments, Hammersmith, London, UK). Serum-free insulin concentrations were measured using a double-antibody radioimmunoassay (Pharmacia Insulin RIA kit, Pharmacia, Uppsala, Sweden) after precipitation with polyethylene glycol. Lactate was measured by enzymatic analysis (16).
Statistics. Group comparisons were performed with ANOVA followed by Tukey's Studentized range test. Pearson's correlations were calculated where appropriate. The statistical computation was performed with the SAS statistical program package (SAS Institute, Cary, NC). The results are expressed as means ± SE.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Characteristics of the study groups.
Body weight was greater in the weight lifters than the endurance
athletes and the sedentary subjects (Table 1). The percent body fat was
lower in both groups of athletes than in the sedentary group (Table 1).
O2max
(ml · kg
1 · min
1)
was markedly increased in the endurance athletes (71 ± 2) but was
similar in the weight lifters (42 ± 2, P < 0.001) and
sedentary subjects (42 ± 2, P < 0.001).
|
|
Whole body and skeletal muscle glucose uptake.
Plasma glucose (5.0 ± 0.1, 4.8 ± 0.1, and 5.0 ± 0.2 mmol/l
in endurance athletes, weight lifters, and sedentary men) and
serum-free insulin concentrations (72 ± 12, 56 ± 4, and
64 ± 6 mU/l, respectively) were comparable during hyperinsulinemia.
The weight lifters and the sedentary men had comparable rates of
insulin-stimulated rates of whole body (38 ± 4 vs. 34 ± 2
µmol · kg 1 · min
1,
weight lifters vs. sedentary men) and femoral muscle (59 ± 12 vs.
63 ± 7 µmol · kg
muscle
1 · min
1,
respectively) glucose uptake. In contrast, the endurance athletes had
enhanced insulin-stimulated rates of glucose uptake at the level of the
whole body (65 ± 3
µmol · kg
1 · min
1,
P < 0.01) and in skeletal muscle (125 ± 16
µmol · kg
muscle
1 · min
1,
P < 0.01) compared with the two other groups (Fig.
2).
O2max and skeletal
muscle glucose uptake were positively correlated (r = 0.67,
P < 0.001), and skeletal muscle and whole body glucose uptake values were correlated with each other (r = 0.84,
P < 0.001). An example of PET images of insulin-stimulated
glucose uptake in skeletal muscle is shown in Fig.
3.
|
|
Heart glucose uptake.
The rate of insulin-stimulated myocardial glucose uptake per gram of
myocardium was 48% lower in the endurance athletes (544 ± 50
µmol · kg
muscle 1 · min
1,
P < 0.01) and 37% lower in the weight lifters
(651 ± 45 µmol · kg
muscle
1 · min
1,
p < 0.01) than in the sedentary men (1,041 ± 78
µmol · kg
muscle
1 · min
1).
Rates of myocardial glucose uptake per unit mass of myocardium were
comparable in the weight lifters and endurance athletes (Fig. 1). Left
ventricular glucose uptake (per gram of myocardium) was also
significantly inversely correlated with left ventricular mass
(r =
0.67, P < 0.001). Examples of PET images
of insulin-stimulated glucose uptake in heart muscle in the three
groups are shown in Fig. 3. In contrast to skeletal muscle, plasma
lactate levels did not correlate with heart glucose uptake, suggesting
that the lower rate of glucose uptake in the weight lifters than the
sedentary men was not due to increased lactate uptake via lactate mass action.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The present study is the first to relate cardiac structural changes to myocardial metabolism in resistance- and aerobically trained subjects. We found the heart to be enlarged in both groups and to utilize less glucose per unit mass than that of sedentary subjects. The rate of glucose uptake was similarly proportional to the degree of left ventricular hypertrophy in both weight lifters and endurance athletes. These similarities in cardiac adaptation were contrasted by a marked difference in the response of skeletal muscle to insulin between the two groups of athletes. In the weight lifters, the rate of insulin-stimulated skeletal muscle glucose uptake was similar to that in the sedentary men, whereas it was markedly enhanced in the endurance-trained athletes.
Both aerobic and resistance training are associated with an increase in left ventricular mass (6, 17, 30). This was also observed in the present study (Fig. 1, Table 2). In keeping with the data of Longhurst and Stebbins (14) and reviews of the literature (5, 9, 14), the absolute left ventricular mass and the left ventricular mass divided by surface area were slightly, albeit not significantly, lower in the weight lifters than in the endurance athletes (Fig. 1, Table 2). Regarding cardiac dimensions, we found, consistent with previous data (5, 9), increases in both posterior and septal wall thicknesses in the endurance athletes and weight lifters compared with the sedentary men. In the meta-analysis of Fagard (6), increases in left ventricular end-diastolic diameter, wall thickness, and left ventricular mass were for endurance athletes 10, 18, and 48%, and for resistance-trained athletes 2.5, 15, and 25%. In our study, respective values were for endurance athletes 8, 27, and 56% and for weight lifters 6, 22, and 42%. Thus, in the present study, the left ventricular end-diastolic diameter in the weight lifters was slightly greater than that predicted from Fagard's meta-analysis. On the other hand, in the study of Spirito et al. (30), in which morphology of the athlete's heart was assessed by echocardiography in two groups of elite athletes, long-distance runners and weight lifters, these athletes had similar left ventricular internal diameters (53.3 vs. 53.3 mm) and wall thicknesses (10.5 mm vs. 10.3 mm) (30). In addition, in a recent study of Fisman et al. (8), 29 endurance athletes and 16 weight lifters were found to have similar increases in both left ventricular mass and in septal and posterior wall thicknesses compared with 20 sedentary subjects. One might argue that these inconsistencies are attributable to confounding effects of dynamic components in resistance-training programs. This was unlikely the case for the weight lifters participating in the present study, because rate of maximal oxygen consumption, an accurate estimate of exposure to dynamic exercise components (14), was identical between the weight lifters and the sedentary men.
Both the endurance athletes and the weight lifters exhibited a significant decrease in insulin-stimulated myocardial glucose uptake per unit weight of the myocardium. Myocardial work, as estimated from the rate-pressure product, was comparable among the groups. When glucose uptake per unit myocardial mass was multiplied by left ventricular mass, all groups utilized equal amounts of glucose. These data are consistent with our previous data showing that glucose uptake under hyperinsulinemic conditions is proportional to cardiac work, irrespective of skeletal muscle insulin sensitivity. For example, the heart in normal men and women utilizes equal amounts of glucose, although insulin sensitivity of skeletal muscles is enhanced in women compared with equally fit men (19). In normotensive patients with insulin-dependent diabetes mellitus (21) and non-insulin-dependent diabetes mellitus (33), insulin resistance is observed in skeletal muscles, but cardiac work and insulin-stimulated glucose uptake in the heart during hyperinsulinemia are unaltered. On the other hand, in patients with essential hypertension, cardiac work is increased as is the rate of insulin-stimulated glucose uptake per unit mass of the myocardium (23). Thus, although structural studies have suggested the heart of a resistance-trained athlete to more closely resemble that of a hypertensive heart, the present data demonstrate that the heart of a resistance-trained athlete is metabolically similar to that of an endurance-trained athlete and is characterized by diminished rather than increased glucose uptake per unit heart mass.
Under hyperinsulinemic conditions such as those prevailing in the present study, serum FFA concentrations are almost completely suppressed. Because FFAs are utilized in a concentration-dependent manner in the human heart (20, 22), and because FFA concentrations were similarly suppressed in all of the three groups, it is unlikely that myocardial rates of FFA utilization differed among the groups. Because FFAs and glucose represent the two most important fuels for the human myocardium under resting aerobic conditions (20, 22), it is unlikely that the lower rates of glucose uptake in the trained groups were due to increased utilization of fuels other than glucose. Consistent with this, direct measurement of rates of myocardial FFA utilization under fasting conditions have not revealed differences between endurance athletes and sedentary subjects (32). Regarding plasma lactate concentrations, the athletes exhibited higher levels during hyperinsulinemia than the two other groups. We have previously demonstrated that plasma lactate concentrations under conditions similar to those employed in the present study are determined by the rate of peripheral glucose uptake (35). A significant relationship between whole body and muscle glucose uptake and plasma lactate concentrations was also observed in the present study. The higher plasma lactate concentration in the endurance athletes might have enhanced lactate utilization in the heart (34). On the other hand, an increase in lactate uptake is unlikely to explain the decrease in myocardial glucose uptake, at least not via lactate mass action, in the weight lifters, because plasma lactate concentrations were comparable between weight lifters and sedentary subjects.
Endurance training is associated with increases in insulin sensitivity of glucose uptake in skeletal muscle, in direct proportion to maximal aerobic power (18, 25, 36). The present study confirms, by direct measurement of glucose uptake in skeletal muscle, that resistance training does not increase insulin-stimulated glucose uptake per unit mass of skeletal muscle (36). The failure of resistance training to enhance muscle insulin sensitivity could be due to the inability of resistance training to increase muscle capillary density (11) or to change muscle fiber types toward an insulin-sensitive direction (27, 31). Of note, the lack of favorable effects of resistance training on insulin sensitivity is also the likely explanation for why serum lipids and lipoproteins (12, 37) do not appear to change in an antiatherogenic direction by this type of training.
The study was performed under euglycemic hyperinsulinemic conditions, which are artificial compared with the fed state. However, we were interested to determine how skeletal muscle insulin sensitivity relates to heart insulin sensitivity, and for this purpose the clamp technique is the golden standard, as it allows tissue glucose uptake measurements to be performed under steady-state conditions. Steady state is a requirement not only for accurate use of PET methodology but also for application of the Fick principle to quantitate tissue glucose uptake by use of conventional techniques. We were not able to measure FFA or lactate uptake, the rate of glucose oxidation, or the contribution of intracellular substrates such as triglycerides and glycogen to energy metabolism. Separate studies, which use for example the fatty acid tracer [18F]fluoro-6-thia-heptadecanoic acid (15) and [15O]O2 (13) to quantitate myocardial fatty acid and oxygen uptake, need to be undertaken to clarify the contribution of FFAs to myocardial substrate utilization and the relationship between myocardial glucose uptake and oxygen consumption under hyperinsulinemic conditions.
In conclusion, the present data demonstrate that the heart of a resistance-trained athlete closely resembles that of an endurance-trained athlete with respect to the rate of glucose uptake during hyperinsulinemia. In both groups of athletes, the rate of glucose uptake per unit mass of myocardium was decreased compared with sedentary men. When the rate of glucose uptake per unit mass was multiplied by heart size, glucose uptake was similar in all groups.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank the technicians of the Turku PET Centre and Jukka Kapanen,
Paavo Nurmi Center, for
O2max determinations.
![]() |
FOOTNOTES |
---|
This work was supported by grants from the Academy of Finland (P. Nuutila, H. Yki-Järvinen), Novo-Nordisk (P. Nuutila, H. Yki-Järvinen), Juselius (P. Nuutila, H. Yki-Järvinen), Aarne Koskelo (T. O. Takala), and the Finnish Medical Foundation (T. O. Takala).
Received 24 August 1998; accepted in final form 4 December 1998.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: T. Takala, Turku PET Centre, Turku University Central Hospital, PO Box 52, FIN-20521 Turku, Finland (E-mail: teetaka{at}utu.fi).
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Blomqvist, C. G.,
and
B. Saltin.
Cardiovascular adaptations to physical training.
Annu. Rev. Physiol.
45:
169-189,
1983[Medline].
2.
DeFronzo, R. A.,
J. D. Tobin,
and
R. Andres.
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
Am. J. Physiol.
237 (Endocrinol. Metab. Gastrointest. Physiol. 6):
E214-E223,
1979
3.
Devereux, R. B.,
and
N. Reichek.
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Circulation
55:
613-618,
1977[Abstract].
4.
Durnin, J. V. G. A.,
and
M. M. Rahaman.
The assessment of the amount of fat in the human body from measurements of skinfold thicknesses.
Br. J. Nutr.
21:
544-550,
1967.
5.
Effron, M. B.
Effects of resistive training on left ventricular function.
Med. Sci. Sports Exerc.
21:
694-697,
1989[Medline].
6.
Fagard, R. H. Athlete's heart: a meta-analysis of the
echocardiographic experience. Int. J. Sports Med. 17, Suppl. 3: S140-S144, 1996.
7.
Fagard, R. H.
Impact of different sports and training on cardiac structure and function.
Cardiol. Clin.
15:
397-412,
1997[Medline].
8.
Fisman, E. Z.,
P. Embon,
A. Pines,
A. Tenenbaum,
Y. Drory,
I. Shapira,
and
M. Motro.
Comparison of left ventricular function using isometric exercise Doppler echocardiography in competitive runners and weightlifters versus sedentary individuals.
Am. J. Cardiol.
79:
355-359,
1997[Medline].
9.
Fleck, S. J. Cardiovascular adaptations to resistance training.
Med. Sci. Sports Exerc. 20, Suppl.: S146-S151,
1988.
10.
Hamacher, K.,
H. H. Coenen,
and
G. Stöcklin.
Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.
J. Nucl. Med.
27:
235-238,
1986[Abstract].
11.
Hepple, R. T.,
S. L. M. Mackinnon,
J. M. Goodman,
S. G. Thomas,
and
M. J. Plyley.
Resistance and aerobic training in older men: effects on O2peak and the capillary supply to skeletal muscle.
J. Appl. Physiol.
82:
1305-1310,
1997
12.
Hurley, B. F.,
J. M. Hagberg,
D. R. Seals,
A. A. Ehsani,
A. P. Goldberg,
and
J. O. Holloszy.
Glucose tolerance and lipid-lipoprotein levels in middle-aged powerlifters.
Clin. Physiol.
7:
11-19,
1987[Medline].
13.
Iida, H.,
C. G. Rhodes,
L. I. Araujo,
Y. Yamamoto,
R. de Silva,
A. Maseri,
and
T. Jones.
Noninvasive quantification of regional myocardial metabolic rate for oxygen by use of 15O2 inhalation and positron emission tomography. Theory, error analysis, and application in humans.
Circulation
94:
792-807,
1996
14.
Longhurst, J. C.,
and
C. L. Stebbins.
The isometric athlete.
Cardiol. Clin.
10:
281-294,
1992[Medline].
15.
Mäki, M.,
M. Haaparanta,
P. Nuutila,
V. Oikonen,
M. Luotolahti,
O. Eskola,
and
J. M. Knuuti.
Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoid acid.
J. Nucl. Med.
39:
1320-1327,
1998[Abstract].
16.
Marbach, E. P.,
and
M. H. Weil.
Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.
Clin. Chem.
13:
314-325,
1967[Medline].
17.
Maron, B. J.
Structural features of the athlete heart as defined by echocardiography.
J. Am. Coll. Cardiol.
7:
190-203,
1986[Medline].
18.
Nuutila, P.,
M. J. Knuuti,
O. J. Heinonen,
U. Ruotsalainen,
M. Teräs,
J. Bergman,
O. Solin,
H. Yki-Järvinen,
L. M. Voipio-Pulkki,
U. Wegelius,
and
V. A. Koivisto.
Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.
J. Clin. Invest.
93:
2267-2274,
1994[Medline].
19.
Nuutila, P.,
M. J. Knuuti,
M. Mäki,
H. Laine,
U. Ruotsalainen,
M. Teräs,
M. Haaparanta,
O. Solin,
and
H. Yki-Järvinen.
Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography.
Diabetes
44:
31-36,
1995[Abstract].
20.
Nuutila, P.,
M. J. Knuuti,
M. Raitakari,
U. Ruotsalainen,
M. Teräs,
L.-M. Voipio-Pulkki,
M. Haaparanta,
O. Solin,
U. Wegelius,
and
H. Yki-Järvinen.
Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans.
Am. J. Physiol.
267 (Endocrinol. Metab. 30):
E941-E946,
1994
21.
Nuutila, P.,
J. Knuuti,
U. Ruotsalainen,
V. A. Koivisto,
E. Eronen,
M. Teräs,
J. Bergman,
M. Haaparanta,
L.-M. Voipio-Pulkki,
J. Viikari,
T. Rönnemaa,
U. Wegelius,
and
H. Yki-Järvinen.
Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.
Am. J. Physiol.
264 (Endocrinol. Metab. 27):
E756-E762,
1993
22.
Nuutila, P.,
V. A. Koivisto,
J. Knuuti,
U. Ruotsalainen,
M. Teras,
M. Haaparanta,
J. Bergman,
O. Solin,
L. M. Voipio Pulkki,
U. Wegelius,
and
H. Yki-Järvinen.
Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.
J. Clin. Invest.
89:
1767-1774,
1992[Medline].
23.
Nuutila, P.,
M. Mäki,
H. Laine,
M. J. Knuuti,
U. Ruotsalainen,
M. Luotolahti,
M. Haaparanta,
O. Solin,
A. Jula,
V. A. Koivisto,
L. M. Voipio-Pulkki,
and
H. Yki-Järvinen.
Insulin action on heart and skeletal muscle glucose uptake in essential hypertension.
J. Clin. Invest.
96:
1003-1009,
1995[Medline].
24.
Patlak, C. S.,
and
R. G. Blasberg.
Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.
J. Cereb. Blood Flow Metab.
5:
584-590,
1985[Medline].
25.
Rosenthal, M.,
W. L. Haskell,
R. Solomon,
A. Widstrom,
and
G. M. Reaven.
Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans.
Diabetes
32:
408-411,
1983[Abstract].
26.
Sahn, D. J.,
A. DeMaria,
J. Kisslo,
and
A. Weyman.
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
Circulation
58:
1072-1083,
1978[Abstract].
27.
Schantz, P.
Capillary supply in hypertrophied human skeletal muscle.
Acta Physiol. Scand.
114:
635-637,
1982[Medline].
28.
Schelbert, H. R.,
E. Henze,
H. R. Schon,
R. Keen,
H. Hansen,
C. Selin,
S. C. Huang,
J. R. Barrio,
and
M. E. Phelps.
C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism.
Am. Heart J.
105:
492-504,
1983[Medline].
29.
Sokoloff, L.,
M. Reivich,
C. Kennedy,
M. H. Des Rosiers,
C. S. Patlak,
K. D. Pettigrew,
O. Sakurada,
and
M. Shinohara.
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.
J. Neurochem.
28:
897-916,
1977[Medline].
30.
Spirito, P.,
A. Pelliccia,
M. A. Proschan,
M. Granata,
A. Spataro,
P. Bellone,
G. Caselli,
A. Biffi,
C. Vecchio,
and
B. J. Maron.
Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports.
Am. J. Cardiol.
74:
802-806,
1994[Medline].
31.
Tesch, P. A.,
A. Thorsson,
and
P. Kaiser.
Muscle capillary supply and fiber type characteristics in weight and power lifters.
J. Appl. Physiol.
56:
35-38,
1984
32.
Turpeinen, A. K.,
J. T. Kuikka,
E. Vanninen,
P. Vainio,
R. Vanninen,
H. Litmanen,
V. A. Koivisto,
K. Bergström,
and
M. I. Uusitupa.
Athletic heart: a metabolic, anatomical, and functional study.
Med. Sci. Sports Exerc.
28:
33-40,
1996[Medline].
33.
Utriainen, T.,
T. Takala,
M. Luotolahti,
T. Rönnemaa,
H. Laine,
U. Ruotsalainen,
M. Haaparanta,
P. Nuutila,
and
H. Yki-Järvinen.
Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
Diabetologia
41:
555-559,
1998[Medline].
34.
Wisneski, J. A.,
W. C. Stanley,
R. A. Neese,
and
E. W. Gertz.
Effects of acute hyperglycemia on myocardial glycolytic activity in humans.
J. Clin. Invest.
85:
1648-1656,
1990[Medline].
35.
Yki-Järvinen, H.,
C. Bogardus,
and
J. E. Foley.
Regulation of plasma lactate concentration in resting human subjects.
Metabolism
39:
859-864,
1990[Medline].
36.
Yki-Järvinen, H.,
and
V. A. Koivisto.
Effects of body composition on insulin sensitivity.
Diabetes
32:
965-969,
1983[Abstract].
37.
Yki-Järvinen, H.,
V. A. Koivisto,
M. R. Taskinen,
and
E. Nikkilä.
Glucose tolerance, plasma lipoproteins and tissue lipoprotein lipase activities in body builders.
Eur. J. Appl. Physiol.
53:
253-259,
1984.